US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 29.175
  • +0.015+0.05%
Trading May 17 13:05 ET
1.60BMarket Cap-108861P/E (TTM)

Supernus Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: May 15, 2024

Based on 3 analysts giving stock ratings to Supernus Pharmaceuticals in the past 3 months

Buy

  • Buy

    66.67%

  • Hold

    33.33%

  • Sell

    0.00%

Price Target

Updated: May 15, 2024

The average Supernus Pharmaceuticals stock price target is 40.67 with a max estimate of 43.00 and a min estimate of 38.00

Review Supernus Pharmaceuticals earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: May 15, 2024

Buy

  • Buy

    66.67%

  • Hold

    33.33%

  • Sell

    0.00%

Price Target

Updated: May 15, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg